Some angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can help decrease proteinuria, 40 and treatment with an ARB has resulted in a 23% reduction in the risk ...

The use of SGLT2 inhibitors, especially dapagliflozin, can lower adiposopathy parameters in patients with CKD, regardless of ...

GLP-1RAs were associated with significant reductions in mean blood glucose and weight compared with controls. The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appears to be beneficial ...

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. Glucagon-like peptide-1 receptor agonists (GLP1-RA) are a ...

Please provide your email address to receive an email when new articles are posted on . Researchers evaluated four increasingly stringent eGFR-based algorithms for patients with CKD. The results could ...

Please provide your email address to receive an email when new articles are posted on . Patients with type 2 diabetes on empagliflozin were significantly less likely to experience a rapid decline in ...

MONDAY, June 9, 2025 (HealthDay News) -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary ...

It is estimated that approximately 25%–30% of hospitalized adults have diabetes. Numerous studies have demonstrated the benefits of technological advances such as continuous glucose monitoring (CGM) ...

Misdiagnosis of Latent Autoimmune Diabetes of Adulthood GLP-1RAs were associated with significant reductions in mean blood glucose and weight compared with controls. GLP-1RAs were associated with ...